Beta-Fuoxymorphamine
![]()  | |
| Names | |
|---|---|
| IUPAC name
 Methyl (2E)-4-{[(5α,6β)-3,14-dihydroxy-17-methyl-4,5-epoxymorphinan-6-yl]amino}-4-oxo-2-butenoate  | |
| Identifiers | |
3D model (JSmol)  | 
|
| Abbreviations | β-FOA | 
| ChEMBL | |
| ChemSpider | |
PubChem CID  | 
|
InChI 
  | |
SMILES 
  | |
| Properties | |
Chemical formula  | 
C22H26N2O6 | 
| Molar mass | 414.458 g·mol−1 | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
Infobox references  | |
beta-Fuoxymorphamine (β-fuoxymorphamine) is an opioid acting at μ-opioid receptors. It is used experimentally.[1][2]
See also
References
- ↑ Portoghese PS, Takemori AE (October 1983). "Different receptor sites mediate opioid agonism and antagonism". Journal of Medicinal Chemistry. 26 (10): 1341–3. doi:10.1021/jm00364a001. PMID 6312042.
 - ↑ Huang W, Manglik A, Venkatakrishnan AJ, Laeremans T, Feinberg EN, Sanborn AL, et al. (August 2015). "Structural insights into µ-opioid receptor activation". Nature. 524 (7565): 315–21. Bibcode:2015Natur.524..315H. doi:10.1038/nature14886. PMC 4639397. PMID 26245379.
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
